Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users
- 8 April 2010
- Vol. 105 (5), 907-913
- https://doi.org/10.1111/j.1360-0443.2010.02905.x
Abstract
Aims Despite proven benefits of antiretroviral therapy (ART), many human immunodeficiency virus (HIV)‐infected injection drug users (IDU) do not access treatment even in settings with free health care. We examined whether methadone maintenance therapy (MMT) increased initiation and adherence to ART among an IDU population with free health care. Design We examined prospectively a cohort of opioid‐using antiretroviral‐naive HIV‐infected IDU and investigated factors associated with initiation of antiretroviral therapy as well as subsequent adherence. Factors associated independently with time to first initiation of antiretroviral therapy were modelled using Cox proportional hazards regression. Findings Between May 1996 and April 2008, 231 antiretroviral‐naive HIV‐infected opioid‐using IDU were enrolled, among whom 152 (65.8%) initiated ART, for an incidence density of 30.5 [95% confidence interval (CI): 25.9–35.6] per 100 person‐years. After adjustment for time‐updated clinical characteristics and other potential confounders, use of MMT was associated independently with more rapid uptake of antiretroviral therapy [relative hazard = 1.62 (95% CI: 1.15–2.28); P = 0.006]. Those prescribed methadone also had higher rates of ART adherence after first antiretroviral initiation [odds ratio = 1.49 (95% CI: 1.07–2.08); P = 0.019]. Conclusion These results demonstrate that MMT contributes to more rapid initiation and subsequent adherence to ART among opioid‐using HIV‐infected IDU. Addressing international barriers to the use and availability of methadone may increase dramatically uptake of HIV treatment among this population.Keywords
This publication has 45 references indexed in Scilit:
- Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugsCMAJ : Canadian Medical Association Journal, 2009
- Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinicsContemporary Clinical Trials, 2009
- The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort studyAddiction, 2008
- The role of harm reduction in controlling HIV among injecting drug usersAIDS, 2008
- Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug usersHIV Medicine, 2008
- Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-upThe Journal of Infectious Diseases, 2008
- Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO)Harm Reduction Journal, 2008
- Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral TherapyAmerican Journal of Epidemiology, 2006
- Staging for Antiretroviral Therapy Among HIV-Infected Drug UsersJama-Journal Of The American Medical Association, 2004
- Drug abuse, methadone treatment, and health services use among injection drug users with AIDSDrug and Alcohol Dependence, 2000